Header Logo

Connection

Oliver Brooks to Respiratory Syncytial Virus, Human

Back to Details
This is a "connection" page, showing publications Oliver Brooks has written about Respiratory Syncytial Virus, Human.
Oliver Brooks
Connection Strength
0.214
Respiratory Syncytial Virus, Human
  1. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023 Aug 25; 72(34):920-925.
    View in: PubMed
    Score: 0.214
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.